The Diabetes business unit at Medtronic (NYSE:MDT) could have some exciting offering in the pipeline, company officials say.

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its ...

Semaglutide (known by its brand name Ozempic) has gained widespread attention for its weight-loss benefits ... However, ...

or sensor-augmented insulin pump therapy (open-loop; n=6834) between 2021 and 2023 were included in this analysis. The primary outcomes were the rates of severe hypoglycemia and diabetic ketoacidosis ...

"Beta Bionics joins IPO uptick, aims to raise $114.4m in Nasdaq listing" was originally created and published by Medical ...

On December 3, 2024, a U.S District Court for the District of Massachusetts jury awarded Plaintiff Insulet Corporation $452 ...

Brand-name medications usually cost more than generics. Part B covers durable insulin pumps worn outside the body and the insulin used in the pump. After you pay your deductible — $257 in 2025 ...